Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Phytocannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC), are plant-derived compounds that interact with the endocannabinoid system (ECS), a neuromodulatory system present throughout the body and brain. The ECS has close interactions with the hypothalamus, a key brain region that regulates homeostasis, appetite, stress response, sleep, and hormone production. Scientific studies have demonstrated that cannabinoid receptors (CB1 and CB2) are expressed in the hypothalamus, and that activation of these receptors by phytocannabinoids can influence hypothalamic functions. For example, THC is known to stimulate appetite through actions on hypothalamic pathways, and both THC and CBD have been shown in animal and some human studies to affect stress responses and circadian rhythms via hypothalamic circuits. Some evidence also suggests phytocannabinoids may influence the hypothalamic-pituitary-adrenal (HPA) axis, which regulates stress hormones like cortisol. However, while mechanistic and animal studies are robust, rigorous clinical trials in humans specifically targeting hypothalamic function are still limited. Thus, while there is a scientific rationale and preliminary evidence for phytocannabinoids supporting hypothalamic processes, more research is needed to clarify efficacy and safety for this specific purpose.

More about phytocannabinoids
More about Hypothalamus

Other ingredients that support Hypothalamus

Other body systems supported by phytocannabinoids

Products containing phytocannabinoids